Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,926 DKK | -4.86% | -5.61% | -10.60% |
May. 21 | Genmab A/S Reaffirms Financial Guidance for 2024 | CI |
May. 21 | Genmab A/S completed the acquisition of ProfoundBio, Inc. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.60% | 18.09B | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B | |
-31.18% | 7.55B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Morgan Stanley Adjusts Price Target on Genmab to $32 From $33, Maintains Underweight Rating